zepbound is tirzepatide Now Available Through LillyDirect: A New Option for Access at a Predictable Price Zepbound 15 mg/0.5 mL injection

We firmly believe that sustainable weight loss should be achieved through science, empathy, and a transparent approach, and this extends to how we guide you through all aspects of your health journey

In patients with type 2 diabetes, tirzepatide was shown to be noninferior and superior to semaglutide in terms of reducing HbA1c levels over a 40-week period

That is a major reason it was recommended as an option for adults with obesity who meet the criteria

Tirzepatide has shown greater average weight loss in clinical trials, with reductions of up to 22% in the SURMOUNT studies

Key Takeaways Eli Lilly is launching singe-use vials of its popular weight-loss drug Zepbound, which will be half the price of previous versions of the drug

This litigation represents people alleging eye injuries from Rybelsus and other GLP-1 drugs